Company Filing History:
Years Active: 2024
Title: Innovations by Philip G Ashton-Rickardt in Neurodegenerative Disease Therapies
Introduction
Philip G Ashton-Rickardt is an accomplished inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of neurodegenerative diseases. His innovative approach focuses on utilizing CAR-Treg-based therapies to address autoimmune components associated with these debilitating conditions.
Latest Patents
Ashton-Rickardt holds a patent for his invention titled "CAR-Treg-based therapies for treating neurodegenerative diseases." This patent outlines compositions and methods designed to suppress autoimmune responses in patients suffering from various neurodegenerative diseases. The invention includes immunosuppressive moieties such as regulatory T cells (Tregs) and proteins expressed by Tregs, which are coupled to a chimeric antigen receptor or proteins that specifically bind to glial cell markers. The patent discloses therapeutically effective doses of these compounds for treating conditions such as progressive supranuclear palsy (PSP), Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), chronic traumatic encephalopathy (CTE), and prion diseases.
Career Highlights
Ashton-Rickardt's career is marked by his dedication to advancing medical science through innovative therapies. His work at Aztherapies, Inc. has positioned him at the forefront of research aimed at developing effective treatments for neurodegenerative diseases. His expertise in immunology and therapeutic development has been instrumental in shaping the direction of his research.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Philip G Ashton-Rickardt's contributions to the field of neurodegenerative disease therapies through his innovative CAR-Treg-based approaches highlight the potential for new treatment modalities. His work continues to inspire advancements in medical science and offers hope for patients suffering from these challenging conditions.